Management of mild cognitive impairment (MCI): The need for national and international guidelines

Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®

(2019) Nagaendran Kandiah et al.   CNS Neuroscience & Therapeutics

Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project

(2019) Ingrid S. van Maurik et al.   Alzheimers Research & Therapy

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey

(2019) Daniela Bertens et al.   Alzheimers Research & Therapy

Relationships Between Cognitive Complaints and Quality of Life in Older Adults With Mild Cognitive Impairment, Mild Alzheimer Disease Dementia, and Normal Cognition

(2018) Shana D. Stites et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study

(2018) Olivia A. Skrobot et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Effect of long-term nutraceutical and dietary supplement use on cognition in the elderly: a 10-year systematic review of randomised controlled trials

(2018) Nathan M. D’Cunha et al.   BRITISH JOURNAL OF NUTRITION

A Survey of Patient and Partner Outcome and Treatment Preferences in Mild Cognitive Impairment

(2018) Glenn E. Smith et al.   JOURNAL OF ALZHEIMERS DISEASE

The Aerobic and Cognitive Exercise Study (ACES) for Community-Dwelling Older Adults With or At-Risk for Mild Cognitive Impairment (MCI): Neuropsychological, Neurobiological and Neuroimaging Outcomes of a Randomized Clinical Trial

(2018) Cay Anderson-Hanley et al.   Frontiers in Aging Neuroscience

Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals

(2018) Jennifer S. Rabin et al.   JAMA Neurology

Reader response: Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

(2018) Michael Valenzuela et al.   NEUROLOGY

Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease

(2018) Gary P. Morris et al.   ACTA NEUROPATHOLOGICA

Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology

(2017) John T O’Brien et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial

(2017) Sandrine Andrieu et al.   LANCET NEUROLOGY

24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial

(2017) Hilkka Soininen et al.   LANCET NEUROLOGY

Lessons from Anti-Amyloid-β Immunotherapies in Alzheimer Disease: Aiming at a Moving Target

(2017) Youmei Wang et al.   Neurodegenerative Diseases

Practice guideline update summary: Mild cognitive impairment

(2017) Ronald C. Petersen et al.   NEUROLOGY

The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures

(2017) Dale S. Sherman et al.   NEUROPSYCHOLOGY REVIEW

Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer’s disease

(2017) Walter E. Müller et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Modern trends in epidemiology of dementia and management of patients with cognitive impairment

(2017) E. E. Vasenina et al.   Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova

Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer’s Biomarkers in Daily Practice (ABIDE) Project

(2017) Ingrid S. van Maurik et al.   JAMA Neurology

A Systematic Review of Neuropsychiatric Symptoms in Mild Cognitive Impairment

(2017) Roberto Monastero et al.   JOURNAL OF ALZHEIMERS DISEASE

Neuropsychiatric Predictors of Progression from Amnestic-Mild Cognitive Impairment to Alzheimer's Disease: The Role of Depression and Apathy

(2017) Katie Palmer et al.   JOURNAL OF ALZHEIMERS DISEASE

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability

(2016) Martijn C. de Wilde et al.   Alzheimers & Dementia

Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment

(2016) Zahinoor Ismail et al.   Alzheimers & Dementia

Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer’s Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects

(2016) Louis De Beaumont et al.   JOURNAL OF ALZHEIMERS DISEASE

Neuropsychological Criteria for Mild Cognitive Impairment and Dementia Risk in the Framingham Heart Study

(2016) Amy J. Jak et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Defeating Alzheimer's disease and other dementias: a priority for European science and society

(2016) Bengt Winblad et al.   LANCET NEUROLOGY

Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease

(2015) Bruno Dubois et al.   Alzheimers & Dementia

The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey

(2015) Martina Bocchetta et al.   Alzheimers & Dementia

Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials

(2015) Andreas Ströhle et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

(2015) Stephanie J. B. Vos et al.   BRAIN

Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer’s disease

(2015) Xu Liu et al.   BRAIN BEHAVIOR AND IMMUNITY

Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies

(2015) Jie-Qiong Li et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761®

(2015) Bruno Scherrer et al.   Journal of Nutrition Health & Aging

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

(2015) Tiia Ngandu et al.   LANCET

Caregiver burden in mild cognitive impairment

(2014) Matt Paradise et al.   AGING & MENTAL HEALTH

Cognitive Behavioral Therapies in older adults with depression and cognitive deficits: a systematic review

(2014) Sharon Sanz Simon et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Efficacy and safety ofGinkgo bilobaextract EGb 761®in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial

(2014) S. I. Gavrilova et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

The Diagnosis and Management of Mild Cognitive Impairment

(2014) Kenneth M. Langa et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Systematic review of strengths and limitations of Randomized Controlled Trials for non-pharmacological interventions in mild cognitive impairment: Focus on Alzheimer’s disease

(2014) T. Horr et al.   Journal of Nutrition Health & Aging

Effects of music therapy on behavioral and psychological symptoms of dementia: A systematic review and meta-analysis

(2013) Tomomi Ueda et al.   AGEING RESEARCH REVIEWS

Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis

(2013) Sofia Lopes da Silva et al.   Alzheimers & Dementia

Treatment for mild cognitive impairment: systematic review

(2013) Claudia Cooper et al.   BRITISH JOURNAL OF PSYCHIATRY

Classification and Epidemiology of MCI

(2013) Rosebud Roberts et al.   CLINICS IN GERIATRIC MEDICINE

Burden of caregivers for patients with mild cognitive impairment in Japan

(2013) Satoshi Hayashi et al.   INTERNATIONAL PSYCHOGERIATRICS

Quality of life in patients with mild cognitive impairment

(2012) Helena Bárrios et al.   AGING & MENTAL HEALTH

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia

(2012) S. Sorbi et al.   EUROPEAN JOURNAL OF NEUROLOGY

A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI

(2012) Oliver Peters et al.   Journal of Nutrition Health & Aging

Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial

(2012) Bruno Vellas et al.   LANCET NEUROLOGY

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Outcomes of Mild Cognitive Impairment by Definition

(2011) Mary Ganguli et al.   ARCHIVES OF NEUROLOGY

Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial

(2011) Natalie Sinn et al.   BRITISH JOURNAL OF NUTRITION

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Alzheimer's disease and other dementias

(2011) Ralf Ihl et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

EFNS guidelines for the diagnosis and management of Alzheimer’s disease

(2010) J. Hort et al.   EUROPEAN JOURNAL OF NEUROLOGY

A Randomized, Double-blind, Placebo Controlled-trial of Triflusal in Mild Cognitive Impairment

(2009) Teresa Gómez-Isla et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

The neuropathology of probable Alzheimer disease and mild cognitive impairment

(2009) Julie A. Schneider et al.   ANNALS OF NEUROLOGY

Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

(2009) R. C. Petersen et al.   NEUROLOGY

Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial

(2009) R. S. Doody et al.   NEUROLOGY

The Effects of Exercise on Cognition in Older Adults With and Without Cognitive Decline: A Systematic Review

(2008) Jannique G Z van Uffelen et al.   CLINICAL JOURNAL OF SPORT MEDICINE

Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications

(2008) Elliott J Mufson et al.   Expert Review of Neurotherapeutics

Ginkgo biloba for Prevention of DementiaA Randomized Controlled Trial

(2008) Steven T. DeKosky   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and efficacy of galantamine in subjects with mild cognitive impairment

(2008) B. Winblad et al.   NEUROLOGY